• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 2
  3. Authors

Online ISSN: 2515-8260

Volume7, Issue2

Cytogenetic and immunological alterations of recurrent bladder cancer

    Shukhrat Ziyadullaev Obid Elmamatov Nodir Raximov Farkhod Raufov

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 2, Pages 1877-1883

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Abstract: In this review, we discussed genetic and immunological changes of bladder
cancer along with relapse of this disease; however, it should be noted that in most cases,
multiple genetic and immunological changes occur simultaneously or mutually dependent
on each other. Many genetic mutations disrupt the function of genes involved in
regulation, and conversely, chromosomal aberrations lead to changes in transcription.
Pathogenesis and transition of normal urothelium of bladder into cancer are multifactorial
processes. Chronic inflammation causes the initiation and progression of the main
pathophysiology of invasive and metastatic cancer. A dichotomy is observed in the role of
immune cells in bladder cancer. Although the immune response protects the bladder by
suppressing tumor growth, certain immune cells including neutrophils, macrophages, and
T-lymphocytes contribute the development and progression of the tumor.
Keywords:
    bladder cancer relapse immune cells cytogenetics chromosomal aberrations
  • PDF (265 K)
  • XML
(2020). Cytogenetic and immunological alterations of recurrent bladder cancer. European Journal of Molecular & Clinical Medicine, 7(2), 1877-1883.
Shukhrat Ziyadullaev; Obid Elmamatov; Nodir Raximov; Farkhod Raufov. "Cytogenetic and immunological alterations of recurrent bladder cancer". European Journal of Molecular & Clinical Medicine, 7, 2, 2020, 1877-1883.
(2020). 'Cytogenetic and immunological alterations of recurrent bladder cancer', European Journal of Molecular & Clinical Medicine, 7(2), pp. 1877-1883.
Cytogenetic and immunological alterations of recurrent bladder cancer. European Journal of Molecular & Clinical Medicine, 2020; 7(2): 1877-1883.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 130
  • PDF Download: 314
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus